144 related articles for article (PubMed ID: 31402218)
1. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
Lommen K; Vaes N; Aarts MJ; van Roermund JG; Schouten LJ; Oosterwijk E; Melotte V; Tjan-Heijnen VC; van Engeland M; Smits KM
Eur Urol Oncol; 2021 Apr; 4(2):215-226. PubMed ID: 31402218
[TBL] [Abstract][Full Text] [Related]
2. Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.
Joosten SC; Deckers IA; Aarts MJ; Hoeben A; van Roermund JG; Smits KM; Melotte V; van Engeland M; Tjan-Heijnen VC
Epigenomics; 2017 Sep; 9(9):1243-1257. PubMed ID: 28803494
[TBL] [Abstract][Full Text] [Related]
3. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
[TBL] [Abstract][Full Text] [Related]
4. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Lasseigne BN; Burwell TC; Patil MA; Absher DM; Brooks JD; Myers RM
BMC Med; 2014 Dec; 12():235. PubMed ID: 25472429
[TBL] [Abstract][Full Text] [Related]
6. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
7. Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker.
de Martino M; Klatte T; Haitel A; Marberger M
Cancer; 2012 Jan; 118(1):82-90. PubMed ID: 21713763
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma.
Kubiliūtė R; Žukauskaitė K; Žalimas A; Ulys A; Sabaliauskaitė R; Bakavičius A; Želvys A; Jankevičius F; Jarmalaitė S
J Cancer Res Clin Oncol; 2022 Feb; 148(2):361-375. PubMed ID: 34689221
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts.
Iafolla MAJ; Picardo S; Aung K; Hansen AR
JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa050. PubMed ID: 33134830
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis.
Sun M; Marconi L; Eisen T; Escudier B; Giles RH; Haas NB; Harshman LC; Quinn DI; Larkin J; Pal SK; Powles T; Ryan CW; Sternberg CN; Uzzo R; Choueiri TK; Bex A
Eur Urol; 2018 Nov; 74(5):611-620. PubMed ID: 29784193
[TBL] [Abstract][Full Text] [Related]
11. CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.
Carter JA; Górecki DC; Mein CA; Ljungberg B; Hafizi S
Epigenetics; 2013 Jul; 8(7):739-47. PubMed ID: 23803643
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.
Kubiliute R; Jarmalaite S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445557
[TBL] [Abstract][Full Text] [Related]
13. Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
Feng Z; Oberije CJG; van de Wetering AJP; Koch A; Wouters KAD; Vaes N; Masclee AAM; Carvalho B; Meijer GA; Zeegers MP; Herman JG; Melotte V; van Engeland M; Smits KM
Clin Transl Gastroenterol; 2022 Jun; 13(6):e00499. PubMed ID: 35584320
[TBL] [Abstract][Full Text] [Related]
14. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol.
Rasti A; Mehrazma M; Madjd Z; Keshtkar AA; Roudi R; Babashah S
BMJ Open; 2016 Jan; 6(1):e009667. PubMed ID: 26729387
[TBL] [Abstract][Full Text] [Related]
16. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
17. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
[TBL] [Abstract][Full Text] [Related]
18. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
[TBL] [Abstract][Full Text] [Related]
19. Cell-Free
Jung M; Ellinger J; Gevensleben H; Syring I; Lüders C; de Vos L; Pützer S; Bootz F; Landsberg J; Kristiansen G; Dietrich D
Clin Chem; 2019 Apr; 65(4):559-568. PubMed ID: 30626634
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature.
Geertsen L; Koldby KM; Thomassen M; Kruse T; Lund L
Eur Urol Open Sci; 2022 Mar; 37():27-35. PubMed ID: 35106503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]